Effect of dopamine deficiency on the preparation of visually guided saccadic eye movements

Zhurnal Vysshei Nervnoi Deyatelnosti Imeni I.P. Pavlova

Volumn 56, Issue 5, 2006, Pages 590-596

  Ratmanova, P O ^a   Napalkov, D A ^a   Bogdanov, R R ^a   Latanov, A V ^a   Turbina, L G ^a   Shulgovsky, V V ^a  

^a NONE

Author keywords

Basal ganglia; Dopamine; Dopamine agonists; Multistep saccade; Parkinson's disease; Saccade; Visually guided saccade

Indexed keywords

DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; PIRIBEDIL;

ARTICLE; DRUG EFFECT; FEMALE; HUMAN; METABOLISM; MIDDLE AGED; PARKINSON DISEASE; PATHOPHYSIOLOGY; SACCADIC EYE MOVEMENT;

DOPAMINE; DOPAMINE AGONISTS; FEMALE; HUMANS; MIDDLE AGED; PARKINSON DISEASE; PIRIBEDIL; SACCADES;

EID: 33847056281     PISSN: 00444677     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Russian source
2. Russian source
3. Russian source
4. Russian source
5. Russian source
6. Russian source
7. Russian source
8. Russian source
9. Russian source
10. Russian source
11. Briand K.A., Strallow D., Hening W., Poizner H., Sereno A.B. Control of voluntary and reflexive saccades in Parkinson's disease//Exp. Brain Res. 1999. V. 129. No 1. P. 38-48.
12. Broerse A., Crawford T.J., den Boer J.A. Parsing cognition in schizophrenia using saccadic eye movements: a selective overview // Neuropsychologia. 2001. V. 39. P. 742-756.
13. Chan F., Armstrong I.T., Pari G., Riopelle R.J., Munoz D.P. Deficits in saccadic eye-movement control in Parkinson's disease // Neuropsychologia. 2005. V. 43. P. 784-796.
14. Fischer B. The preparation of visually guided saccades // Rev. Physiol. Biochem. Pharmacol. 1987. V. 106. P. 1-35.
15. Fischer B., Weber H., Biscaldi M., Aiple F., Otto P., Stuhr V. Separate populations of visually guided saccades in humans: reaction times and amplitudes // Exp. Brain Res. 1993. V. 92. No 3. P. 528-541.
16. Fukushima J., Fukushima K., Miyasaka K., Yamashita I. Voluntary control of saccadic eye movement in patients with frontal cortical lesions and parkinsonian patients in comparison with that in schizophrenics // Biol. Psychiatry. 1994. V. 36. No 1. P. 21-30.
17. Gerfen C.R. Molecular effects of dopamine on striatal-projection pathways // Trends Neurosci. 2000. V. 23. No 10. P. 64-70.
18. Hikosaka O., Takikawa Y., Kawagoe R. Role of the basal ganglia in the control of purposive saccadic eye movements // Phis. Rev. 2000. V. 80. No 3. P. 953-978.
19. Hughes A.J., Daniel S.E., Blankson L., Lees A. A clinicopathologic study of 100 cases of Parkinson's disease // Arch. Neurol. 1993. V. 50. P. 140-148.
20. Kimmig H., Haußmann K., Mergner T., Lücking C.H. What is pathological with gaze shift fragmentation in Parkinson's disease? // J. Neurol. 2002. V. 249. P. 683-692.
21. Munoz D.P., Everling S. Look away: The anti-saccade task and the voluntary control of eye movement // Nat. Rev. Neurosci. 2004. V. 5. P. 218-228.
22. Roll A., Wierzbicka M.M., Wolf W. The "gap paradigm" leads to express-like saccadic reaction times in Parkinson's disease // Exp. Brain Res. 1996. V. 111. No 1. P. 131-138.
23. Yoshida H., Yamada T., Matsuzaki H. Reflexive and voluntary saccades in Parkinson's disease // Nippon Ganka Gakkai Zasshi. 2002. V. 106. No 5. P. 281-286.